EB-101

· Abeona Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for EB-101, covering 2022-12-05 to 2025-06-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients [Phase 3]

See pricing